Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bertram

Showing results (201-210 of 244) with videos related to

Pageof 25
Sort By:
Alzheimer'S & Dementia (New York, N. Y.)|January 1, 2020
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohortDaniel Stamate, Min Kim, Petroula Proitsi, et al.
Nature|November 12, 2013
Dysfunctional nitric oxide signalling increases risk of myocardial infarctionJeanette Erdmann, Klaus Stark, Ulrike B Esslinger, et al.
Translational Psychiatry|November 23, 2020
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery datasetShengjun Hong, Dmitry Prokopenko, Valerija Dobricic, et al.
Medrxiv : the Preprint Server for Health Sciences|September 5, 2025
Redefining ALS: Large-scale proteomic profiling reveals a prolonged pre-diagnostic phase with immune, muscular, metabolic, and brain involvementJan Homann, Roxanna Korologou-Linden, Vivian Viallon, et al.
Research Square|September 15, 2025
Redefining ALS: Large-scale proteomic profiling reveals a prolonged pre-diagnostic phase with immune, muscular, metabolic, and brain involvementJan Homann, Roxanna Korologou-Linden, Vivian Viallon, et al.
Journal of Medical Genetics|September 14, 2012
Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjectsChristina M Lill, Tian Liu, Brit-Maren M Schjeide, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2019
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohortMin Kim, Stuart Snowden, Tommi Suvitaival, et al.
Nature Genetics|July 28, 2014
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's diseaseMike A Nalls, Nathan Pankratz, Christina M Lill, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisTing-Chen Wang, Jigyasha Timsina, Chenyang Jiang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2021
Replication study of plasma proteins relating to Alzheimer's pathologyLiu Shi, Laura M Winchester, Sarah Westwood, et al.
Pageof 25

Showing results (201-210 of 244) with videos related to

Sort By:
Pageof 25
Alzheimer'S & Dementia (New York, N. Y.)|January 1, 2020
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohortDaniel Stamate, Min Kim, Petroula Proitsi, et al.
Nature|November 12, 2013
Dysfunctional nitric oxide signalling increases risk of myocardial infarctionJeanette Erdmann, Klaus Stark, Ulrike B Esslinger, et al.
Translational Psychiatry|November 23, 2020
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery datasetShengjun Hong, Dmitry Prokopenko, Valerija Dobricic, et al.
Medrxiv : the Preprint Server for Health Sciences|September 5, 2025
Redefining ALS: Large-scale proteomic profiling reveals a prolonged pre-diagnostic phase with immune, muscular, metabolic, and brain involvementJan Homann, Roxanna Korologou-Linden, Vivian Viallon, et al.
Research Square|September 15, 2025
Redefining ALS: Large-scale proteomic profiling reveals a prolonged pre-diagnostic phase with immune, muscular, metabolic, and brain involvementJan Homann, Roxanna Korologou-Linden, Vivian Viallon, et al.
Journal of Medical Genetics|September 14, 2012
Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjectsChristina M Lill, Tian Liu, Brit-Maren M Schjeide, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2019
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohortMin Kim, Stuart Snowden, Tommi Suvitaival, et al.
Nature Genetics|July 28, 2014
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's diseaseMike A Nalls, Nathan Pankratz, Christina M Lill, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisTing-Chen Wang, Jigyasha Timsina, Chenyang Jiang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2021
Replication study of plasma proteins relating to Alzheimer's pathologyLiu Shi, Laura M Winchester, Sarah Westwood, et al.
Pageof 25